Citrine
Diurnal and Citrine sign licensing agreement for Alkindi
January 27, 2021Research and Development Citrine, Diurnal
Diurnal Group has entered into an exclusive licence agreement for its product Alkindi (hydrocortisone granules in capsules for opening) with …
Latest content
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
EnteroBiotix appoints former GSK Chief Medical Officer to board
November 3, 2026
